Bringing health stories to the front page

Bringing health stories to the front page

‏التالي

Dialogues: a conversation with Kinari Webb

Dialogues is a new series from the Global Health Matters podcast where we bring you interviews featuring fresh perspectives on global health issues. The goal of each Dialogues is to break through the echo chambers that exist in global health through in-depth, thoughtf ...

  عرض المزيد

Bonus episode: What’s behind your favourite podcast?

This bonus episode is slightly different as our Executive Producer and Host <a href='https://can01.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwitter.com%2FGarryAslanyan&data=05%7C02%7Cobadiah.george%40utoronto.ca%7C21f9a47b7e1645d74fb908dc74ccf0e8%7C78aac2262f034 ...

  عرض المزيد

‏حلقات موصى بها

Introduction to Global Health
The Rx Bricks Podcast

<h2 id="header-9c83a0c4947a4ff482f264ddb56bfda5" class="brick-header brick-header-primary markup-enabled medium-editor-element" role="textbox" data-rxannotationdata="content.text" data-medium-editor-element="true" aria-multiline="true" data-medium-editor-editor-index="1" data-pla ...  عرض المزيد

Let's Diagnose Global Health Today | Dr Slim Slama
The afikra Podcast

The CEO of the World Innovation Summit for Health (WISH), Dr Slim Slama, joins us on this episode of The afikra Podcast to give an in-depth look into the complexities and challenges facing global health today, including the rise of non-communicable diseases, the impact of urba ...

  عرض المزيد

Youth skills in a rapidly changing world
Our World, Connected

Meet Dr John Mugo and Beria Wawira – two colleagues on a mission to empower millions of young people and parents through the Zizi Afrique Foundation in Kenya. In conversation with host Christine Wilson, they ask: are we preparing young people for success in today’s fast-paced ...

  عرض المزيد

#22 Reforming pharmacovigilance education – Michael Reumerman
Drug Safety Matters

Send a text message to the show!Healthcare professionals are key players in medicines safety but they often lack the time or knowledge to report adverse drug reactions. To change that, we need to urgently rethink how we teach pharmacovigilance, argues Michael Reumerman from Amste ...  عرض المزيد